Efficacy and safety of systemic treatments for moderate‐to‐severe psoriasis: meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of systemic treatments for moderate‐to‐severe psoriasis: meta‐analysis of randomized controlled trials

Published:2014-02 Issue:2 Volume:170 Page:274-303
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Schmitt J.¹²,Rosumeck S.³,Thomaschewski G.¹,Sporbeck B.³,Haufe E.¹²,Nast A.³

Affiliation:

1. Centre for Evidence‐Based Healthcare University Hospital Carl Gustav Carus Technische Universität Dresden Fetscherstraße 74 D‐01307 Dresden Germany

2. Department of Occupational and Social Medicine Medical Faculty Carl Gustav Carus Technische Universität Dresden Fetscherstraße 74 D‐01307 Dresden Germany

3. Division of Evidence Based Medicine (dEBM) Department of Dermatology Charité – Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.12663

Reference68 articles.

1. Pathogenesis and clinical features of psoriasis

2. Quality of Life in Patients with Psoriasis: A Systematic Literature Review

3. Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment Dissatisfaction

4. Work Limitations and Productivity Loss Are Associated with Health-Related Quality of Life but Not with Clinical Severity in Patients with Psoriasis

5. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis — a structural equations modeling approach

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients;Archives of Dermatological Research;2024-05-24

2. Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience;Journal of Dermatological Treatment;2023-08-02

3. Liver disease among patients with psoriasis: the Malaysian Psoriasis Registry;Clinical and Experimental Dermatology;2023-01-12

4. Nanoformulations Enabled Possible Solutions for the Management of Psoriasis;Current Cosmetic Science;2022-09

5. The Value of Indirect Comparisons of Systemic Biologics for Psoriasis: Interpretation of Efficacy Findings;Dermatology and Therapy;2022-07-14